MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Huntington Disease-Like 2: A Case Presentation and Review of the Literature

J. Pleen, V. Saini, N. Doher, R. Walker, V. Singh (Kansas City, KS, USA)

Meeting: 2019 International Congress

Abstract Number: 309

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis, Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics, Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology

Session Information

Date: Monday, September 23, 2019

Session Title: Choreas (Non-Huntington’s Disease)

Session Time: 1:45pm-3:15pm

Location: Les Muses, Level 3

Objective: To present a case of Huntington Disease-Like 2 (HDL2). HDL2 is rare and phenotypically similar to Huntington’s Disease (HD). However the gene, chromosome, and repeat expansion are distinct.

Background: The patient is a 72 year-old African American male whose symptoms have been progressing over 10 years. He initially presented with hallucinations, abnormal movements in the left arm, head nodding, and frequent throat clearing. The patient’s symptoms progressed to severe dysarthria, choreiform movements in his legs and lips. He is now wheelchair-bound. Family history is significant for multiple family members diagnosed with HD.

Method: Patient underwent brain MRI, neuropsychological testing, and targeted genetic analysis for pathogenic variants. Additionally, a pedigree and a review of the literature is presented.

Results: MRI brain showed supratentorial involutional changes disproportionate to the patient’s age. Neuropsychological testing revealed deficits in memory (1st percentile), abstract reasoning (2nd percentile), and nonverbal skills (2nd percentile). The overall score was below the 1st percentile. Targeted genetic analysis for pathogenic variants found 42 repeats of CAG/CTG in junctophilin-3 (JPH3) gene, which confirmed the diagnosis of HLD2.

Conclusion: While similar in phenotype to HD, HDL2 is caused by an expansion of CAG/CTG triplets in exon 2A of the JPH3 gene on chromosome band 16q24. HDL2 is a neurodegenerative disease without any disease-modifying pharmacological treatment, which progresses to death 10 to 20 years from diagnosis. Given the recent development of promising disease-modifying therapies for HD, it will become increasingly important from a clinical perspective to identify patients who will not respond to therapy due to differences in genotype.

References: 1. Anderson DG, Walker RH, Connor M, Carr J, Margolis RL, Krause A. A Systematic Review of the Huntington Disease-Like 2 Phenotype. Huntingtons Dis. 2017;6(1):37-46. 2. Rodrigues GG, Walker RH, Brice A, Cazeneuve C, Russaouen O, Teive HA, Munhoz RP, Becker N, Raskin S, Werneck LC, Junior WM, Tumas V. Huntington’s disease-like 2 in Brazil-report of 4 patients. Mov Disord. 2008 Nov 15;23(15):2244-7.

To cite this abstract in AMA style:

J. Pleen, V. Saini, N. Doher, R. Walker, V. Singh. Huntington Disease-Like 2: A Case Presentation and Review of the Literature [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/huntington-disease-like-2-a-case-presentation-and-review-of-the-literature/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/huntington-disease-like-2-a-case-presentation-and-review-of-the-literature/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley